The co-pathogenesis of influenza viruses with bacteria in the lung.

McCullers, Jonathan A.·2014·Nature Reviews Microbiology

Cited by (723)

Items 101–200 of 723

  1. Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae
    Ulrike Grienke, Martina Richter, Elisabeth Walther, Anja Hoffmann, Johannes Kirchmair, Vadim Makarov, Sándor Nietzsche, Michaela Schmidtke, Judith Maria Rollinger · 2016 · Scientific Reports
  2. Streptococcus pneumoniae colonization of the nasopharynx is associated with increased severity during respiratory syncytial virus infection in young children
    Jaelle C. Brealey, Keith Joseph Chappell, Sally Galbraith, Emmanuelle Fantino, Jane Gaydon, Sarah J. Tozer, Paul R. Young, Patrick G. Holt, Peter David Sly · 2017 · Respirology
  3. Host‐pathogen kinetics during influenza infection and coinfection: insights from predictive modeling
    Amber M. Smith · 2018 · Immunological Reviews
  4. Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection
    Bellinghausen, Carla, Gulraiz, Fahad, Heinzmann, Alexandra C. A., Dentener, Mieke A., Savelkoul, Paul H. M., Wouters, Emiel F., Rohde, Gernot G., Stassen, Frank R. · 2016 · Respiratory Research
  5. Infant Mouse Model for the Study of Shedding and Transmission during Streptococcus pneumoniae Monoinfection
    M. Ammar Zafar, Masamitsu Kono, Yang Wang, Tonia Zangari, Jeffrey N. Weiser · 2016 · Infection and Immunity
  6. Viral–bacterial interactions in the respiratory tract
    Carla Bellinghausen, Gernot G. U. Rohde, Paul H. M. Savelkoul, Emiel F.�M. Wouters, Frank R. M. Stassen · 2016 · Journal of General Virology
  7. Dynamic Virus-Bacterium Interactions in a Porcine Precision-Cut Lung Slice Coinfection Model: Swine Influenza Virus Paves the Way for Streptococcus suis Infection in a Two-Step Process
    Fandan Meng, Nai‐Huei Wu, Andreas G. Nerlich, Georg Herrler, Peter Valentin‐Weigand, Maren Seitz · 2015 · Infection and Immunity
  8. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model
    Hao Wang, Desiree Anthony, Selcuk Yatmaz, Odilia L. C. Wijburg, Catherine Satzke, Bruce David Levy, Ross Vlahos, Steven Bozinovski · 2017 · Clinical Science
  9. Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis
    Gennaro DE PASCALE, Flavio De Maio, Simone Carelli, Giulia De Angelis, Margherita Cacaci, Luca Maria Montini, Giuseppe Bello, Salvatore Lucio Cutuli, Gabriele Pintaudi, Eloisa Sofia Tanzarella et al. · 2021 · Critical Care
  10. Influenza virus N-linked glycosylation and innate immunity
    Ian A. York, James Stevens, Irina V. Alymova · 2018 · Bioscience Reports
  11. Point-of-care testing for respiratory viruses in adults: The current landscape and future potential
    Nathan James Brendish, Hannah F. Schiff, Tristan William Clark · 2015 · Journal of Infection
  12. N-glycosylation, a leading role in viral infection and immunity development
    V. K. Pandey, Rajani Sharma, G. Prajapati, T. Mohanta, A. K. Mishra · 2022 · Molecular Biology Reports
  13. Postviral Complications
    Jason E. Prasso, Jane C. Deng · 2016 · Clinics in Chest Medicine
  14. Role of biofilm in children with recurrent upper respiratory tract infections
    Erica Nazzari, Sara Torretta, Lorenzo Pignataro, Paola Marchisio, Susanna Esposito · 2014 · European Journal of Clinical Microbiology & Infectious Diseases
  15. Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs
    Paul S. Kim, Yo Han Jang, Soon Young Kwon, Chung Lee, Gyoonhee Han, Baik Lin Seong · 2018 · Viruses
  16. Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections
    Elizabeth R. Aguilera, Laurel L. Lenz · 2020 · Frontiers in Immunology
  17. Influenza A virus infection predisposes hosts to secondary infection with different Streptococcus pneumoniae serotypes with similar outcome but serotype-specific manifestation.
    Sharma-Chawla, Niharika, Sender, Vicky, Kershaw, Olivia, Gruber, Achim D., Volckmar, Julia, Henriques-Normark, Birgitta, Stegemann-Koniszewski, Sabine, Bruder, Dunja · 2016 · Infection and Immunity
  18. Necrotizing pneumonia (aetiology, clinical features and management)
    Maria Krutikov, Ananna Rahman, Simon Tiberi · 2019 · Current Opinion in Pulmonary Medicine
  19. Advanced Research in Porcine Reproductive and Respiratory Syndrome Virus Co-infection With Other Pathogens in Swine
    Dengshuai Zhao, Bo Yang, Xingguo Yuan, Chaochao Shen, Dajun Zhang, Xijuan Shi, Ting Zhang, Huimei Cui, Jinke Yang, Xuehui Chen et al. · 2021 · Frontiers in Veterinary Science
  20. Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected Children
    Natalie I Mazur, Louis Bont, Adam L. Cohen, Cheryl Cohen, Anne von Gottberg, Michelle J. Groome, Orienka Hellferscee, Kerstin Klipstein‐Grobusch, Omphile Mekgoe, Fathima Naby et al. · 2016 · Clinical Infectious Diseases
  21. Coinfection of SARS-CoV-2 and Other Respiratory Pathogens
    Ling Ma, Wenjing Wang, Jehane Michael Le Grange, Xiaorong Wang, Shuaixian Du, Chen Li, Wei Jia, Jinnong Zhang · 2020 · Infection and Drug Resistance
  22. Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches
    Ailar Sabbaghi, Seyed Mohammad Miri, Mohsen Keshavarz, Mehran Mahooti, Arghavan Zebardast, Amir Ghaemi · 2020 · Virology Journal
  23. Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract
    Joseph A. Lewnard, Katia J. Bruxvoort, Heidi J. Fischer, Vennis X. Hong, Lindsay R. Grant, Luis Jódar, Bradford D. Gessner, Sara Yee Tartof · 2021 · The Journal of Infectious Diseases
  24. A review of the role of Haemophilus influenzae in community-acquired pneumonia
    Mary Slack · 2015 · Pneumonia
  25. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection
    Kelly M. Shepardson, Kyle Larson, Rachelle V. Morton, Justin R. Prigge, Edward E. Schmidt, Victor C. Huber, Agnieszka Rynda‐Apple · 2016 · mBio
  26. Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus
    Vikram Gopal, Benjamin E. Nilsson-Payant, Hollie French, Jurre Y. Siegers, Wai‐Shing Yung, Matthew J. Hardwick, Aartjan J.W. te Velthuis · 2021 · ACS Applied Materials & Interfaces
  27. Defining the balance between optimal immunity and immunopathology in influenza virus infection
    Thi H. O. Nguyen, Louise C. Rowntree, Brendon Yew Loong Chua, Ryan S. Thwaites, Katherine Kedzierska · 2024 · Nature reviews. Immunology
  28. Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
    François Trottein, Christophe Paget · 2018 · Frontiers in Immunology
  29. Metagenomic comparison of tracheal aspirate and mini-bronchial alveolar lavage for assessment of respiratory microbiota
    Charles Langelier, Katrina Kalantar, Farzad Moazed, Michael R. Wilson, Emily D. Crawford, Thomas J. Deiss, Annika Belzer, Samaneh Bolourchi, Saharai Caldera, Monica Fung et al. · 2019 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  30. Severe Pneumonia Caused by Coinfection With Influenza Virus Followed by Methicillin-Resistant Staphylococcus aureus Induces Higher Mortality in Mice
    Leili Jia, Jiangyun Zhao, Chaojie Yang, Yuan Liang, Pengwei Long, Xiao Liu, Shaofu Qiu, Ligui Wang, Jing Xie, Hao Li et al. · 2019 · Frontiers in Immunology
  31. Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia
    Abdulaziz Alqahtani, Edrous Alamer, Mushtaq Ahmad Mir, Ali Alasmari, Mohammed Merae Alshahrani, Mohammed Asiri, Irfan S. Ahmad, Abdulaziz Alhazmi, Abdullah A. Algaissi · 2022 · International Journal of Environmental Research and Public Health
  32. A Toll-Like Receptor 5 Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza Virus-Associated Pneumococcal Mouse Infections
    Rémi Porte, Delphine Fougeron, Natalia Muñoz‐Wolf, Julien Tabareau, Anne‐France Georgel, Fréderic Wallet, Christophe Paget, François Trottein, Jose Alejandro Chabalgoity, Christophe Carnoy et al. · 2015 · Antimicrobial Agents and Chemotherapy
  33. Influenza-associated aspergillosis in critically-ill patients—a retrospective bicentric cohort study
    Frederike Waldeck, Filippo Boroli, Noémie Suh, Pedro David Wendel‐Garcia, Domenica Flury, Julia Notter, Anne Iten, Laurent Kaiser, Jacques Schrenzel, Katia Boggian et al. · 2020 · European Journal of Clinical Microbiology & Infectious Diseases
  34. A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
    Merika Treants Koday, Jorgen Nelson, Aaron A. Chevalier, Michael Koday, Hannah Maryam Kalinoski, Lance J. Stewart, Lauren P. Carter, Travis Nieusma, Peter S. Lee, Andrew B. Ward et al. · 2016 · PLoS Pathogens
  35. Alteration of Flt3-Ligand-dependent de novo generation of conventional dendritic cells during influenza infection contributes to respiratory bacterial superinfection
    Ranin Y. Beshara, Valentin Sencio, Daphnée Soulard, Adeline Barthélémy, Josette Fontaine, Thibault Pinteau, Lucie Deruyter, Mohamad Bachar Ismail, Christophe Paget, Jean‐Claude Sirard et al. · 2018 · PLoS Pathogens
  36. IL-6 Prevents Lung Macrophage Death and Lung Inflammation Injury by Inhibiting GSDME- and GSDMD-Mediated Pyroptosis during Pneumococcal Pneumosepsis
    Xuemei Gou, Wenchun Xu, Yusi Liu, Peng Yang, Wenlong Xu, Yibing Yin, Xuemei Zhang · 2022 · Microbiology Spectrum
  37. Mechanisms of Epithelial Immunity Evasion by Respiratory Bacterial Pathogens
    Lokesh Sharma, Jingjing Feng, Clemente J. Britto, Charles S. Dela Cruz · 2020 · Frontiers in Immunology
  38. Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis
    Javier Arranz-Herrero, Jesús Presa, Sergio Rius‐Rocabert, Alberto Utrero‐Rico, José Ángel Arranz-Arija, Antonio Lalueza, María Marta Escribese, Jordi Ochando, Vincent Soriano, Estanislao Nistal‐Villán · 2023 · International Journal of Infectious Diseases
  39. The role of influenza in the epidemiology of pneumonia
    Sourya Shrestha, Betsy Foxman, Joshua M. Berus, Willem Gijsbert van Panhuis, Claudia Steiner, Cecile G. Viboud, Pejman Rohani · 2015 · Scientific Reports
  40. The dual role of innate immunity during influenza
    Carmelo Biondo, Germana Lentini, Concetta Beninati, Giuseppe Teti · 2019 · Biomedical Journal
  41. IL-6 During Influenza-Streptococcus pneumoniae Co-Infected Pneumonia—A Protector
    Xuemei Gou, Jun Yuan, Hong Wang, Xiaofang Wang, Jiangming Xiao, Jingyi Chen, Shuang Liu, Yibing Yin, Xuemei Zhang · 2020 · Frontiers in Immunology
  42. A Sulfathiazole–Amantadine Hydrochloride Cocrystal: The First Codrug Simultaneously Comprising Antiviral and Antibacterial Components
    Ling‐Yang Wang, Fan-Zhi Bu, Yan‐Tuan Li, Zhi‐Yong Wu, Cui‐Wei Yan · 2020 · Crystal Growth & Design
  43. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions
    Yasemin Genç Bahçe, Ömer Acer, Osman Özüdoğru · 2022 · Microbial Pathogenesis
  44. Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus
    Joseph A. Lewnard, Louis F Fries, Iksung Cho, Janice Chen, Ramanan Laxminarayan · 2022 · Proceedings of the National Academy of Sciences
  45. The Effect of Influenza Virus on the Human Oropharyngeal Microbiome
    Elisa Ramos‐Sevillano, William G. Wade, Alex Mann, Anthony Gilbert, Rob Lambkin‐Williams, Ben Killingley, Jonathan S. Nguyen‐Van‐Tam, Christoph M. Tang · 2018 · Clinical Infectious Diseases
  46. Microorganisms as scaffolds of host individuality: an eco-immunity account of the holobiont
    Lynn Chiu, Gérard Eberl · 2016 · Biology & Philosophy
  47. Material-herbology: An effective and safe strategy to eradicate lethal viral-bacterial pneumonia
    Jun Li, Ziao Zhou, Xiangmei Liu, Yufeng Zheng, Changyi Li, Zhenduo Cui, Kwk Yeung, Hongbo Zhou, Jiahui Zou, Zhaoyang Li et al. · 2021 · Matter
  48. Enhanced Pathogenesis Caused by Influenza D Virus and Mycoplasma bovis Coinfection in Calves: a Disease Severity Linked with Overexpression of IFN-γ as a Key Player of the Enhanced Innate Immune Response in Lungs
    Adrien Lion, Aurélie Sécula, Camille Rançon, Olivier Boulesteix, Anne Pinard, Alain Deslis, Sara Hägglund, Elias Salem, Hervé Cassard, Katarina Näslund et al. · 2021 · Microbiology Spectrum
  49. Efficient suilysin-mediated invasion and apoptosis in porcine respiratory epithelial cells after streptococcal infection under air-liquid interface conditions
    F. Meng, Nai-Huei Wu, Maren Seitz, G. Herrler, P. Valentin-Weigand · 2016 · Scientific Reports
  50. Association of sputum microbiota profiles with severity of community-acquired pneumonia in children
    Melinda M. Pettigrew, Janneane F. Gent, Yong Kong, Martina Wade, Shane Gansebom, Anna M. Bramley, Seema Jain, Sandra L. R. Arnold, Jonathan A. McCullers · 2016 · BMC Infectious Diseases
  51. Hierarchical effects of pro-inflammatory cytokines on the post-influenza susceptibility to pneumococcal coinfection
    Stefanie Duvigneau, Niharika Sharma-Chawla, Alessandro Boianelli, Sabine Stegemann‐Koniszewski, Vān Kính Nguyễn, Dunja Bruder, Esteban Abelardo Hernandez-Vargas · 2016 · Scientific Reports
  52. A Critical, Nonlinear Threshold Dictates Bacterial Invasion and Initial Kinetics During Influenza
    Amber M. Smith, Amanda Pfaff Smith · 2016 · Scientific Reports
  53. Viral strategies predisposing to respiratory bacterial superinfections
    Giovanni Arturo Rossi, Hani Fanous, Andrew A. Colin · 2020 · Pediatric Pulmonology
  54. A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Juthaporn Cowan, Logan Gaudet, Sunita Mulpuru, Vicente Corrales‐Medina, Steven Hawken, Chris G Cameron, Shawn David Aaron, D. William Cameron · 2015 · PLoS ONE
  55. The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia
    Ronald Anderson, Charles H. Feldman · 2016 · Seminars in Respiratory and Critical Care Medicine
  56. Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia
    Ho Namkoong, Makoto Ishii, Hideki Fujii, Kazuma Yagi, Takahiro Asami, Takanori Asakura, Shoji Suzuki, Ahmed E. Hegab, Hirofumi Kamata, Sadatomo Tasaka et al. · 2018 · PLoS Pathogens
  57. Porcine alveolar macrophage polarization is involved in inhibition of porcine reproductive and respiratory syndrome virus (PRRSV) replication
    Longtao WANG, Shouping HU, Qiang Liu, Yiru LI, Lu Xu, Zhuo Zhang, Xuehui Cai, Xijun He · 2017 · Journal of Veterinary Medical Science
  58. ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy
    Ramesh Kumar Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta, Sumita Raha, Kalipada Pahan · 2021 · Journal of Neuroimmune Pharmacology
  59. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function
    Zhiping Yang, Terry Ting-Yu Chiou, Thomas P. Stossel, Lester Kobzik · 2015 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  60. Polymicrobial community‐acquired pneumonia: An emerging entity
    Catia Cillóniz, Rok Čivljak, Antonello Nicolini, Antoní Torres · 2015 · Respirology
  61. Viruses in cystic fibrosis patients’ airways
    Lisa Billard, Rozenn Le Berre, Léa Pilorgé, Christopher Payan, Geneviève Héry-Arnaud, Sophie Vallet · 2017 · Critical Reviews in Microbiology
  62. The prevalence of influenza bacterial co-infection and its role in disease severity: A systematic review and meta-analysis
    Mengling Qiao, Gary Moyes, Fuyu Zhu, You Li, Xin Wang · 2023 · Journal of Global Health
  63. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: influenza life-cycle and currently available drugs
    Roberto Gasparini, Daniela Amicizia, Piero Luigi Lai, Nicola Luigi Bragazzi, Donatella Panatto · 2015 · Journal of preventive medicine and hygiene
  64. Dual Acting Neuraminidase Inhibitors Open New Opportunities to Disrupt the Lethal Synergism between Streptococcus pneumoniae and Influenza Virus
    Elisabeth Walther, Zhongli Xu, Martina Richter, Johannes Kirchmair, Ulrike Grienke, Judith Maria Rollinger, Andi Krumbholz, Hans Peter Saluz, Wolfgang Pfister, Andreas Sauerbrei et al. · 2016 · Frontiers in Microbiology
  65. Prevention of influenza virus induced bacterial superinfection by standardized Echinacea purpurea , via regulation of surface receptor expression in human bronchial epithelial cells
    Selvarani Vimalanathan, R Schoop, Andy Suter, James B. Hudson · 2017 · Virus Research
  66. Natural products against acute respiratory infections: Strategies and lessons learned
    Julia Langeder, Ulrike Grienke, Ya Chen, Johannes Kirchmair, Michaela Schmidtke, Judith Maria Rollinger · 2019 · Journal of Ethnopharmacology
  67. 1918 pandemic influenza virus and Streptococcus pneumoniae co‐infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans
    Kathie‐Anne Walters, Felice D’Agnillo, Zong‐Mei Sheng, Jason Kindrachuk, Louis M. Schwartzman, Rolf E. Kuestner, Daniel S. Chertow, Basil Golding, Jeffery K. Taubenberger, John C. Kash · 2015 · The Journal of Pathology
  68. Lethal Synergism between Influenza and Streptococcus pneumoniae
    Jennifer M. Rudd · 2016 · Journal of Infectious Pulmonary Diseases
  69. Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System
    Meredith J. Crane, Kayla M. Lee, Ethan S. FitzGerald, Amanda Mercedes Jamieson · 2018 · Frontiers in Immunology
  70. Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy
    Elizabeth Q. Littauer, Ioanna Skountzou · 2018 · Frontiers in Immunology
  71. Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia
    Claire Nicolas de Lamballerie, Andrés Pizzorno, Julia Dubois, Thomas Julien, Blandine Padey, Mendy Bouveret, Aurélien Traversier, Catherine Legras‐Lachuer, Bruno Lina, Guy Boivin et al. · 2019 · Scientific Reports
  72. Volatile scents of influenza A and S. pyogenes (co-)infected cells
    Selina Traxler, Gina Barkowsky, Radost A. Saß, Ann‐Christin Klemenz, Nadja Patenge, Bernd Kreikemeyer, Jochen K. Schubert, Wolfram Miekisch · 2019 · Scientific Reports
  73. Acute infectious diseases occurring in the Taï chimpanzee population: a review
    Livia Victoria Patrono, Fabian Hubertus Leendertz · 2019 · Cambridge University Press eBooks
  74. An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens
    Victoria Meliopoulos, Lee-Ann Van de Velde, Nicholas C. van de Velde, Erik A. Karlsson, Geoffrey A. M. Neale, Peter Vogel, Cliff S. Guy, Shalini Sharma, Susu Duan, Sherri L. Surman et al. · 2016 · PLoS Pathogens
  75. Interleukin-7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell response
    Maya Hassane, Youenn Jouan, Florent Creusat, Daphnée Soulard, Chloé Boisseau, Loïc Gonzalez, Emmanuel Christian Patin, Nathalie Heuzé‐Vourc'h, Jean‐Claude Sirard, Christelle Faveeuw et al. · 2019 · Mucosal Immunology
  76. Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT Proteins
    Yaron Drori, Jasmine Jacob‐Hirsch, Rakefet Pando, Aharona Glatman‐Freedman, Nehemya Friedman, Ella Mendelson, Michal Mandelboim · 2020 · Viruses
  77. Respiratory Bacteria Stabilize and Promote Airborne Transmission of Influenza A Virus
    Hannah M. Rowe, Brandi Livingston, Elisa B. Margolis, Amy Davis, Victoria Meliopoulos, Haley Echlin, Stacey Schultz‐Cherry, Jason W. Rosch · 2020 · mSystems
  78. Interaction between Intestinal Parasites and the Gut Microbiota: Implications for the Intestinal Immune Response and Host Defence
    Jensine A. Grondin, Asif Jamal, Sadrina Afrin Mowna, Tyler C. Seto, Waliul Islam Khan · 2024 · Pathogens
  79. Pneumolysin as a potential therapeutic target in severe pneumococcal disease
    Ronald Anderson, Charles H. Feldman · 2017 · Journal of Infection
  80. Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia
    Muzo Wu, John G. Gibbons, Glen M. DeLoid, Alice S. Bedugnis, Rajesh Kumar Thimmulappa, Shyam S. Biswal, Lester Kobzik · 2017 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  81. Compromised Defenses: Exploitation of Epithelial Responses During Viral-Bacterial Co-Infection of the Respiratory Tract
    Jeffrey A. Melvin, Jennifer M. Bomberger · 2016 · PLoS Pathogens
  82. The Role of IL-22 in Viral Infections: Paradigms and Paradoxes
    Silvia Gimeno Brias, Gabrielle Stack, Maria A. Stacey, Alec Redwood, Ian Robert Humphreys · 2016 · Frontiers in Immunology
  83. Post-Glycosylation Modification of Sialic Acid and Its Role in Virus Pathogenesis
    Simon Jigwan Park · 2019 · Vaccines
  84. Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways
    Vicky Sender, Karina Hentrich, Anuj Kumar Pathak, Alicia Qian Ler Tan, Bethel Tesfai Embaie, Susanna L. Lundström, Massimiliano Gaetani, Jan Bergstrand, Rei Nakamoto, Lok‐To Sham et al. · 2020 · Proceedings of the National Academy of Sciences
  85. Lethal Coinfection of Influenza Virus and Streptococcus pneumoniae Lowers Antibody Response to Influenza Virus in Lung and Reduces Numbers of Germinal Center B Cells, T Follicular Helper Cells, and Plasma Cells in Mediastinal Lymph Node
    Yuet Wu, Wenwei Tu, Kwok-Tai Lam, Kin‐Hung Chow, Pak‐Leung Ho, Yi Guan, Joseph S. Malik Peiris, YL Lau · 2014 · Journal of Virology
  86. Factors Associated With Fatality Due to Avian Influenza A(H7N9) Infection in China
    Shufa Zheng, Qianda Zou, Xiaochen Wang, Jiaqi Bao, Fei Yu, Feifei Guo, Peng Liu, Yinzhong Shen, Yimin Wang, Shigui Yang et al. · 2019 · Clinical Infectious Diseases
  87. Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonization
    Soner Yildiz, Joao P. P. Bonifacio, Matthieu Bergé, Víctor González‐Ruiz, Damian Baud, Joachim Kloehn, Inês Boal‐Carvalho, Olivier P. Schären, Michael Schotsaert, Lucy Jane Hathaway et al. · 2020 · eLife
  88. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City
    Mariana Velez-Pintado, Antonio Camiro-Zúñiga, Mercedes Aguilar-Soto, Dalia Cuenca, Moisés Mercado, Brenda Crabtree‐Ramírez, the ARMII study gruop · 2021 · Medical Mycology
  89. How recent advances in molecular tests could impact the diagnosis of pneumonia
    David R. Murdoch · 2016 · Expert Review of Molecular Diagnostics
  90. Microorganisms associated with respiratory syncytial virus pneumonia in the adult population
    Marion Jeannoël, Gérard Lina, Jean‐Philippe Rasigade, Bruno Lina, Florence Morfin, Jean‐Sébastien Casalegno · 2018 · European Journal of Clinical Microbiology & Infectious Diseases
  91. Macrophage adaptation in airway inflammatory resolution
    Manminder Kaur, Thomas Bell, Samira Salek‐Ardakani, Tracy Hussell · 2015 · European Respiratory Review
  92. Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection
    Alessandro Boianelli, Niharika Sharma-Chawla, Dunja Bruder, Esteban Abelardo Hernandez-Vargas · 2016 · Frontiers in Cellular and Infection Microbiology
  93. Mathematical Modeling of Streptococcus pneumoniae Colonization, Invasive Infection and Treatment
    Elisa Domínguez‐Hüttinger, Neville J. Boon, Thomas B. Clarke, Reiko J. Tanaka · 2017 · Frontiers in Physiology
  94. The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza
    Amber M. Smith, Victor C. Huber · 2017 · Viral Immunology
  95. Secondary Bacterial Pneumonia by Staphylococcus aureus Following Influenza A Infection Is SaeR/S Dependent
    Timothy R. Borgogna, Bennett Stephen Hisey, Emily Heitmann, Joshua J. Obar, Nicole N. Meissner, Jovanka M. Voyich · 2018 · The Journal of Infectious Diseases
  96. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection
    Tomoko Sumitomo, Masanobu Nakata, Satoshi Nagase, Yuki Takahara, Mariko Honda-Ogawa, Yasushi Mori, Yukako Akamatsu, Masaya Yamaguchi, Shigefumi Okamoto, Shigetada Kawabata · 2021 · mBio
  97. Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model
    Laura Seldeslachts, Lore Vanderbeke, Astrid Fremau, Agustin Reséndiz-Sharpe, Cato Jacobs, Bo Laeveren, Tessa Ostyn, Lieve M. J. Naesens, Matthias Brock, Frank L. van de Veerdonk et al. · 2021 · Virulence
  98. Faecalibacterium duncaniae as a novel next generation probiotic against influenza
    Loïc Chollet, Séverine Heumel, Lucie Deruyter, Fabrice Bouilloux, Lou Delval, Véronique Robert, Marie-Hélène Gevaert, Muriel Pichavant, Valentin Sencio, Cyril Robil et al. · 2024 · Frontiers in Immunology
  99. Review of Mathematical Modeling of the Inflammatory Response in Lung Infections and Injuries
    Sarah B. Minucci, Rebecca L. Heise, Angela Reynolds · 2020 · Frontiers in Applied Mathematics and Statistics
  100. Induction of cyclophilin A by influenza A virus infection facilitates group A Streptococcus coinfection
    Xiaoyuan Bai, Wenxian Yang, Xiaohan Luan, Huizi Li, Heqiao Li, Deyu Tian, Wenhui Fan, Jing Li, Beinan Wang, Wenjun Liu et al. · 2021 · Cell Reports